The role of cytokines in the changes in bone turnover following bone marrow transplantation

Osteoporosis International

Volumn 13, Issue 1, 2002, Pages 62-68

  Lee, W Y ^a   Kang, M I ^a   Oh, E S ^a   Oh, K W ^a   Han, J H ^a   Cha, B Y ^a   Lee, K W ^a   Son, H Y ^a   Kang, S K ^a   Kim, C C ^a,b  

^a Department of Internal Medicine ^*  (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Bone marrow transplantation; Bone turnover markers; Cytokinesl; Osteoporosis

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; CYTOKINE; INTERLEUKIN 6; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDE; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE ATROPHY; BONE MASS; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; GONAD DYSFUNCTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; BONE REMODELING; CYTOKINES; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-6; MALE; OSTEOPOROSIS; PREDNISOLONE; PROSPECTIVE STUDIES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18244379350     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s198-002-8339-5     Document Type: Article

References (23)

1. Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation
2. Mechanisms of bone loss following allogeneic and autologous hematopoietic stem cell transplantation
3. The short-term changes of bone mineral metabolism following bone marrow transplantation
4. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
5. Bone marrow, cytokines and bone remodeling
6. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
7. Interleukin-6 and soluble interleukin-6 receptors found in synovial fluids are responsible for inducing joint disruption in patients with rheumatoid arthritis
8. Interleukin 6: A potential autocrine/paracrine factor in Paget's disease of bone
9. Bone disease after liver transplantation
10. Rapid loss of vertebral mineral density after renal transplantation
11. Osteoporosis and bone morbidity in cardiac transplant recipients
12. Reduction of bone mass in women after bone marrow transplantation
13. Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism
14. The effects of bone marrow transplantation on osteoblastic differentiation of the human bone marrow-derived stromal cells
15. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor
16. Bone histology in renal transplant patients receiving cyclosporin
17. Stromal cell-mediated stimulation of osteoclastogenesis
18. Relationship between bone metabolism and plasma cytokine levels in patients at risk of post-transplantation bone disease after bone marrow transplantation
19. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation
20. Interleukin-6 levels in febrile children during maximal aplasia after bone marrow transplantation are similar to those in children with normal hematopoiesis
21. Serum interleukin-6 levels during bone marrow transplantation: Impact on transplantation-related toxicity and engraftment
22. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis
23. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption: A clinical research center study